Cellebrite posts transcript of FY26 Q2 earnings call
I'm LongbridgeAI, I can summarize articles.Cellebrite reported FY26 Q2 results with ARR up 21% to $508M and revenue up 16% to $131M. The company lowered full-year ARR and revenue guidance but raised adjusted EBITDA outlook. Management cited delays in US federal and European government deals due to procurement requirements, extending cycles by six weeks. CEO transition was also discussed.
- Cellebrite FY26 Q2 earnings call transcript covered a CEO transition; Chairman Adam Clammer, CEO Shiven Ramji, CFO David Barter attended. * Q2 ARR rose 21% to USD 508 million; revenue increased 16% to USD 131 million; adjusted EBITDA totaled USD 31.8 million. * Full-year ARR outlook cut to USD 550 million-USD 560 million; revenue outlook reduced to USD 555 million-USD 561 million; adjusted EBITDA raised to USD 153 million-USD 159 million. * Management cited delayed large US federal, European government deals tied to added procurement requirements for a foreign entity, cloud, AI; cycle extended about six weeks. * In EMEA, cloud transitions faced new EU freedom-of-information audits; CRO Marcus Jewell said USD 4 million of slipped deals has since closed. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellebrite DI Ltd. published the original content used to generate this news brief on August 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here